This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Facklam, R. Articles by Tyrrell, G. Search for Related Content PubMed PubMed Citation Articles by Facklam, R. Articles by Tyrrell, G.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2003, p. 2587-2592, Vol. 41, No. 6
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.6.2587-2592.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Phenotypic Description and Antimicrobial Susceptibilities of Aerococcus sanguinicola Isolates from Human Clinical Samples

Centers for Disease Control and Prevention, Atlanta, Georgia 30333,¹ National Center for Streptococcus, Edmonton, Alberta, Canada T6G 2J2²

Received 22 October 2002/ Accepted 28 February 2003

This report describes the clinical sources and phenotypic characterization of 16 isolates of Aerococcus sanguinicola. Sixteen conventional tests were used to describe and differentiate the 16 isolates of A. sanguinicola from 30 strains of Aerococcus viridans, 27 strains of Aerococcus urinae, and a single strain each of Aerococcus christensenii and Aerococcus urinaehominis. The phenotypic characterizations of the type strains for each species and 14 A. sanguinicola isolates were also compared in the two reference laboratories. A. sanguinicola are catalase-negative, vancomycin-susceptible, gram-positive cocci arranged in clusters and tetrads, as are all Aerococcus species except A. christensenii (which is arranged in short chains). All 16 isolates of A. sanguinicola were leucine aminopeptidase and pyrrolidonylarylamidase positive, which is unique to this species among the aerococci. All A. sanguinicola isolates grew in broth containing 6.5% NaCl, hydrolyzed hippurate, and were variable in the bile-esculin test. None of the isolates deaminated arginine or were Voges-Proskauer positive. The type strain of A. sanguinicola was isolated from a blood culture of a patient living in Denmark. Seven additional isolates were from patients living in Canada, all with urinary tract infections (six were female). Eight isolates were from patients living in five different states in the United States; five were from patients with urinary tract infections, and three were from blood cultures of one patient each with pneumonia, suspected endocarditis, and unknown clinical conditions. The antimicrobial susceptibility patterns were unremarkable; all isolates tested were susceptible to penicillin, amoxicillin, cefotaxime, cefuroxime, erythromycin, chloramphenicol, vancomycin, quinupristin-dalfopristin (Synercid), rifampin, linezolid, and tetracycline. Six of the 15 cultures were resistant to ciprofloxacin and levofloxacin, but all 15 strains were susceptible to sparfloxacin. High-level resistance was detected for meropenem (2 strains) and trimethoprim-sulfamethonazole (1 strain). Intermediate resistance was detected for trimethoprim-sulfamethoxazole (10 strains) and clindamycin (3 strains).

This article has been cited by other articles:

• Martin, V., Vela, A. I., Gilbert, M., Cebolla, J., Goyache, J., Dominguez, L., Fernandez-Garayzabal, J. F. (2007). Characterization of Aerococcus viridans Isolates from Swine Clinical Specimens. J. Clin. Microbiol. 45: 3053-3057 [Abstract] [Full Text]  
• Vela, A. I., Garcia, N., Latre, M. V., Casamayor, A., Sanchez-Porro, C., Briones, V., Ventosa, A., Dominguez, L., Fernandez-Garayzabal, J. F. (2007). Aerococcus suis sp. nov., isolated from clinical specimens from swine. Int. J. Syst. Evol. Microbiol. 57: 1291-1294 [Abstract] [Full Text]